{"id":"https://openalex.org/W4361959772","doi":"https://doi.org/10.1158/1078-0432.c.6528002","title":"Data from Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma","display_name":"Data from Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361959772","doi":"https://doi.org/10.1158/1078-0432.c.6528002"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6528002","doi":"https://doi.org/10.1158/1078-0432.c.6528002","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6528002","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6528002","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054221810","display_name":"Pok Fai Wong","orcid":"https://orcid.org/0009-0008-4283-662X","observed_orcids":["https://orcid.org/0009-0008-4283-662X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pok Fai Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323732","display_name":"Wei Wei","orcid":"https://orcid.org/0000-0002-6244-3187","observed_orcids":["https://orcid.org/0000-0002-6244-3187","https://orcid.org/0000-0002-3117-9598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058805895","display_name":"James William Smithy","orcid":"https://orcid.org/0000-0003-3126-1193","observed_orcids":["https://orcid.org/0000-0003-3126-1193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W. Smithy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3126-1193","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015572904","display_name":"Bal\u00e1zs \u00c1cs","orcid":"https://orcid.org/0000-0002-0972-4633","observed_orcids":["https://orcid.org/0000-0002-0972-4633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balazs Acs","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0972-4633","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019551393","display_name":"Maria I Toki","orcid":"https://orcid.org/0000-0002-7074-7148","observed_orcids":["https://orcid.org/0000-0002-7074-7148"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria I. Toki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066496998","display_name":"Kim Blenman","orcid":"https://orcid.org/0000-0001-6070-0728","observed_orcids":["https://orcid.org/0000-0001-6070-0728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim R.M. Blenman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6070-0728","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Zelterman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Zelterman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001175430","display_name":"Harriet M. Kluger","orcid":"https://orcid.org/0000-0002-4932-9873","observed_orcids":["https://orcid.org/0000-0002-4932-9873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harriet M. Kluger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9120000004768372},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8830000162124634},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cd20-b-cells","display_name":"CD20+ B cells","score":0.8080000281333923},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.5260000228881836},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9100000262260437},{"id":"https://openalex.org/keywords/multiplex-immunofluorescence","display_name":"multiplex immunofluorescence","score":0.8500000238418579},{"id":"https://openalex.org/keywords/quantitative-immunofluorescence","display_name":"quantitative immunofluorescence","score":0.9639999866485596},{"id":"https://openalex.org/keywords/companion-diagnostics","display_name":"companion diagnostics","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8018996119499207},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6966567039489746},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6447355151176453},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.6091359257698059},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5966147184371948},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.5492774844169617},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5459129810333252},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4433850646018982},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.42742660641670227},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42396125197410583},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.4231397807598114},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32109296321868896},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23448213934898376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.22765791416168213},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.20876893401145935},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20043280720710754},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11657059192657471},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.096819669008255}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6528002","doi":"https://doi.org/10.1158/1078-0432.c.6528002","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6528002","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6528002","doi":"https://doi.org/10.1158/1078-0432.c.6528002","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6528002","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2910849865","https://openalex.org/W2886382494","https://openalex.org/W4395064480","https://openalex.org/W2785869969","https://openalex.org/W2980952992","https://openalex.org/W4410816348","https://openalex.org/W2891779271","https://openalex.org/W4417226281","https://openalex.org/W4400164046","https://openalex.org/W2947916202"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Because":[1],"durable":[2],"response":[3,103,131,221],"to":[4,13,58,81,87],"programmed":[5],"cell":[6,83,120,192],"death":[7],"1":[8],"(PD-1)":[9],"inhibition":[10],"is":[11,217],"limited":[12],"a":[14],"subset":[15],"of":[16,186,190],"melanoma":[17,47,181],"patients,":[18],"new":[19],"predictive":[20],"biomarkers":[21],"could":[22,34],"have":[23],"clinical":[24],"utility.":[25],"We":[26],"hypothesize":[27],"that":[28],"pretreatment":[29],"tumor-infiltrating":[30],"lymphocyte":[31],"(TIL)":[32],"profiles":[33],"be":[35],"associated":[36,150,179,218],"with":[37,50,101,151,155,180,219],"response.":[38],"Experimental":[39],"Design:":[40],"Pretreatment":[41,116,214],"whole":[42],"tissue":[43],"sections":[44],"from":[45],"94":[46],"patients":[48],"treated":[49],"anti\u2013PD-1":[51,220],"therapy":[52],"were":[53,77,99,161],"profiled":[54],"by":[55,90,96,109,119],"multiplex":[56],"immunofluorescence":[57,92],"perform":[59],"TIL":[60,67,94,145,226],"quantification":[61],"(CD4,":[62],"CD8,":[63],"CD20)":[64],"and":[65,85,112,167],"assess":[66],"activation":[68,146],"(CD3,":[69],"GZMB,":[70],"Ki67).":[71],"Two":[72],"independent":[73],"image":[74],"analysis":[75,227],"technologies":[76],"used:":[78],"inForm":[79],"(PerkinElmer)":[80],"determine":[82],"counts,":[84],"AQUA":[86],"measure":[88],"protein":[89],"quantitative":[91],"(QIF).":[93],"parameters":[95],"both":[97],"methodologies":[98],"correlated":[100],"objective":[102],"or":[104,122,129,135],"disease":[105],"control":[106],"rate":[107],"(ORR/DCR)":[108],"RECIST":[110],"1.1":[111],"survival":[113,157],"outcome.":[114,152],"Results:":[115],"lymphocytic":[117,215],"infiltration,":[118],"counts":[121],"QIF,":[123],"was":[124,149,177],"significantly":[125],"higher":[126],"in":[127,133,164,173,183,222,232],"complete":[128],"partial":[130],"than":[132],"stable":[134],"progressive":[136],"disease,":[137],"particularly":[138],"for":[139,169,209,230],"CD8":[140,153,176,191],"(P":[141],"<":[142],"0.0001).":[143],"Neither":[144],"nor":[147],"dormancy":[148],"associations":[154,172],"progression-free":[156],"(HR":[158],">":[159],"3)":[160],"independently":[162],"significant":[163],"multivariable":[165],"analyses":[166],"accounted":[168],"similar":[170],"CD3":[171],"anti\u2013PD-1-treated":[174],"patients.":[175],"not":[178],"prognosis":[182],"the":[184,200],"absence":[185],"immunotherapy.":[187],"Predictive":[188],"performance":[189],"count":[193],"(and":[194],"QIF)":[195],"had":[196],"an":[197,237],"area":[198],"under":[199],"ROC":[201],"curve":[202],"above":[203],"0.75":[204],"(ORR/DCR),":[205],"which":[206],"reached":[207],"0.83":[208],"ipilimumab":[210],"plus":[211],"nivolumab.":[212],"Conclusions:":[213],"infiltration":[216],"metastatic":[223],"melanoma.":[224],"Quantitative":[225],"has":[228],"potential":[229],"application":[231],"digital":[233],"precision":[234],"immuno-oncology":[235],"as":[236],"\u201cindicative\u201d":[238],"companion":[239],"diagnostic.":[240]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-05T00:00:00"}